KINIKSA PHARMACEUTICALS news, videos and press releases
For more news please use our advanced search feature.
KINIKSA PHARMACEUTICALS - More news...
KINIKSA PHARMACEUTICALS - More news...
- Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference
- Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution
- Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024
- Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart
- Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution
- Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
- Kiniksa Pharmaceuticals Provides Corporate Update
- Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference
- Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio Execution
- Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023
- Kiniksa Pharmaceuticals Reports Second Quarter 2023 Financial Results and Recent Portfolio Execution
- Kiniksa Pharmaceuticals to Report Second Quarter 2023 Financial Results on July 25, 2023
- Kiniksa Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare Conference
- Kiniksa Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent Portfolio Execution
- Kiniksa Pharmaceuticals to Report First Quarter 2023 Financial Results on May 2, 2023
- Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Portfolio Execution
- Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2022 Financial Results on February 28, 2023
- Kiniksa Pharmaceuticals to Present at 41st Annual J.P. Morgan Healthcare Conference
- Kiniksa Pharmaceuticals to Present at Bank of America Securities 2022 Biotech SMID Cap Conference
- Kiniksa Pharmaceuticals to Present at Evercore ISI 5th Annual HealthCONx Conference
- Kiniksa Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
- Kiniksa Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 1, 2022
- Kiniksa Pharmaceuticals Announces Closing of Global License Agreement with Genentech for Vixarelimab
- Kiniksa Pharmaceuticals to Present at 2022 Wedbush PacGrow Healthcare Conference
- Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
- Kiniksa Pharmaceuticals Announces Global License Agreement with Genentech for Vixarelimab
- Kiniksa Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 3, 2022
- Kiniksa Pharmaceuticals to Report First Quarter 2022 Financial Results on May 3, 2022
- Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
- Kiniksa Pharmaceuticals and Huadong Medicine Announce Strategic Collaboration